- Home
- EYPT vs SVV Comparison
EYPT vs SVV Comparison
Compare EYPT & SVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EYPT | SVV |
|---|---|---|
| Founded | 1987 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Other Specialty Stores |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2005 | 2021 |
Fundamental Metrics
Financial Performance| Metric | EYPT | SVV |
|---|---|---|
| Price | $12.86 | $7.83 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | ★ $31.80 | $13.67 |
| AVG Volume (30 Days) | ★ 1.2M | 1.0M |
| Earning Date | 03-04-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.14 |
| Revenue | $7,539,000.00 | ★ $1,678,954,000.00 |
| Revenue This Year | N/A | $6.91 |
| Revenue Next Year | $1,031.72 | $7.58 |
| P/E Ratio | ★ N/A | $55.79 |
| Revenue Growth | N/A | ★ 9.19 |
| 52 Week Low | $3.91 | $6.68 |
| 52 Week High | $19.11 | $13.89 |
Technical Indicators
Market Signals| Indicator | EYPT | SVV |
|---|---|---|
| Relative Strength Index (RSI) | 36.53 | 31.61 |
| Support Level | $12.05 | $7.70 |
| Resistance Level | $13.32 | $11.03 |
| Average True Range (ATR) | 1.01 | 0.37 |
| MACD | -0.33 | -0.01 |
| Stochastic Oscillator | 3.45 | 7.12 |
Price Performance
Historical ComparisonAbout EYPT EyePoint Pharmaceuticals Inc.
EyePoint Inc focuses on developing and commercializing innovative therapeutics for serious retinal diseases. It develops therapies for serious retinal diseases to provide durable treatments that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained release product candidate for retinal diseases with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.
About SVV Savers Value Village Inc.
Savers Value Village Inc is a for-profit thrift operator in the United States and Canada. It purchases second-hand textiles (i.e., clothing, bedding, and bath items), shoes, accessories, housewares, books, and other goods from its non-profit partners (NPPs), either directly from them or via on-site donations (OSDs) at Community Donation Centers at its stores. The company then processes, selects, prices, and sells these items in its stores.